Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial

Saved in:
Bibliographic Details
Published inLeukemia Vol. 37; no. 11; pp. 2276 - 2281
Main Authors Fechina, Larisa, Popov, Alexander, Tsaur, Grigory, Henze, Guenter, Shorikov, Egor, Makarova, Olga, Khlebnikova, Olga, Zhukova, Yulia, Arakaev, Oleg, Streneva, Olga, Verzhbitskaya, Tatiana, Riger, Tatiana, Solodovnikov, Alexander, Lapotentova, Elena, Aleinikova, Olga, Myakova, Natalia, Boichenko, Elmira, Kondratchik, Konstantin, Nikonova, Olga, Shapochnik, Alexander, Goroshkova, Marina, Ponomareva, Natalia, Novichkova, Galina, Karachunskiy, Alexander, Roumiantsev, Alexander
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.11.2023
Subjects
Acute lymphoblastic leukemia
Babies
Chemotherapy
Gene Rearrangement
Hematology
Hospitals
Humans
Immunology
Induction therapy
Infant
Leukemia
Lymphatic leukemia
Medical prognosis
Multivariate analysis
Myeloid-Lymphoid Leukemia Protein - genetics
Oncology
Pediatrics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Remission (Medicine)
Retinoic acid
Tretinoin - therapeutic use
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-023-02034-4